Tabula Rasa Healthcare (TRHC) PT Lowered to $95 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Tabula Rasa HealthCare (TRHC) Reports Acquisition of Cognify
November 8, 2018 8:32 AM ESTTabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, recently completed the acquisition of healthcare technology company, Cognify.
Founded in San Francisco in 1998, Cognify is focused on enabling patient-centered, multidisciplinary, coordinated and integrated care along... More
Tabula Rasa Healthcare (TRHC) PT Raised to $91 at Chardan Capital Markets
November 7, 2018 9:06 AM ESTChardan Capital Markets analyst Steven Wardell raised the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $91.00 (from $77.00) while maintaining a Buy rating.
The analyst commented, "Tuesday before market, Management reported a revenue beat and raised topline guidance for the... More
